Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trials

類似資料

• Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trial
  著者:: Siena, Salvatore, 等
  出版事項: (2016)
• Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials
  著者:: Taieb, Julien, 等
  出版事項: (2017)
• Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials
  著者:: Taieb, Julien, 等
  出版事項: (2018)
• Cabozantinib and Panitumumab for RAS Wild‐Type Metastatic Colorectal Cancer
  著者:: Strickler, John H., 等
  出版事項: (2021)
• Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials
  著者:: Peeters, Marc, 等
  出版事項: (2018)